Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines is seeking a Director, Stakeholder Engagement, Europe to lead the implementation of a comprehensive European congress strategy for Medical Affairs, across all oncology therapeutic areas. The role will drive alignment across internal and external stakeholders, ensure high-quality execution of congress activities, and deliver medical leadership and consistent excellence in congresses.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines